04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Under Florida law, similar to that of other states, an insurer’s duty to defend is generally determ...
Read More >
According to the DOJ. I finally had a chance to read the brief of the Solicitor General in the R.G....
Read More >
The U.S. Supreme Court recently agreed to hear Rutledge v. Pharmaceutical Care Management Associatio...
Read More >
Employers, plan sponsors, and plan administrators ring in the New Year with new recordkeeping and ad...
Read More >
American pet owners are probably all familiar with Chewy, an e-commerce pet food and products suppli...
Read More >
The Departments of Labor, Health and Human Services and Treasury recently issued joint final regulat...
Read More >